More importantly, although Apolipoprotein E (APOE) gene polymorphic alleles are a major determinant for Alzheimer disease and play an important role in the risk of vascular dementia [19, 20], whether the APOE genotypes may modify the association glucosamine use and dementia risk has not been examined in the older population. The gene discussed is APOE; the disease is Alzheimer disease.